In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Cog fog can paint columnist Ahna Crum into a corner where nothing flows. As in an early art experiment, she now has a process ...

Black people with MS walk slower and cover shorter distances than white patients, even when some social determinants are ...

Founded in 1946, the National Multiple Sclerosis Society funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their ...

Denise Mihell decided to move to the Glen Elm Mobile Home Community in 2015 to be near her mother and help care for her ...

The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

Discover how Dr. Clara Doran created Noggin’s OOMPH, the nootropic supplement designed to boost focus, energy & brain health ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although Merck is providing it to the NHS in England at a confidential discount. The new guidance is due to be finalised in April, with ...